Evie Ring developer Movano Health has been granted three more patents – two in the USA and one in China – safeguarding the Californian company’s systems and methods for radio frequency-enabled health monitoring.

Designed for women, Evie is sleek, intelligent and comfortable, providing users with medical grade health data that are translated into personalised insights delivered through a mobile app, with no monthly subscription. 

The patents give specific protection for health parameters of blood glucose levels, blood pressure and heart rate.

These patents extend Movano Health’s IP portfolio to 21 patents issued and 38 pending. Of note is US Pat 11,583,199, a foundational patent that enables Movano Health to measure health metrics using amplitude or phase information from its proprietary system-on-chip (SoC).

“We are committed to elevating the standards of wearable health technology and aim to create more accurate, flexible and cost-effective wearables that monitor health metrics, including glucose and blood pressure, non-invasively and without a cuff,” said John Mastrototaro, CEO of Movano Health. “To do so, we’re taking a different approach than our predecessors in the wearable space. Rather than using optical sensors, we’ve made a significant investment in developing a proprietary RF-enabled SoC. Our SoC gives us the opportunity for increased accuracy, is more compact, allowing us to build smaller devices and the materials are more cost-effective. These new patents are a crucial component of protecting our investment in RF and our SoC, and they are helping us emerge as a leader in RF within the health space.”

The SoC combines multiple antennas and a variety of frequencies in the small RF-enabled integrated circuit (IC) designed for blood pressure or glucose monitoring. Movano Health has spent more than five years building this sensor technology from the ground up in an effort to achieve an unprecedented level of precision in health monitoring.

The SoC is being integrated into Movano Health’s smallest wrist worn wearable to date and will be tested in clinical studies in March 2023. After further testing, the company plans to incorporate the SoC into its wearable devices in the future.

The three patents are:

• US Pat 11,583,199 for health monitoring using radio waves that include mixing signals at different frequencies: This core patent covers an RF-based health monitoring device that includes signal processing circuits specifically designed to improve RF-based health monitoring.
• US Pat 11,576,586 for methods for radio wave-based health monitoring that use data derived from amplitude and/or phase data: This patent covers methods for health monitoring that include signal processing techniques designed to improve RF-based health monitoring.
• Chinese Pat ZL201980084505.1 covering methods and systems for multi-band radar-based sensing: This patent covers an RF multi-band chip and represents the company’s effort to secure IP protection for its RF chip architecture in key foreign jurisdictions.

Founded in 2018, Movano Health is developing a suite of purpose-driven healthcare offerings to bring medical-grade, high-quality data to the forefront of consumer health devices. The devices capture a picture of a person’s health information and translate the data into personalised and intelligent insights that empower consumers to live healthier and more balanced lives.